Galectin Therapeutics Inc.

Contributing Author

Recent Articles by Galectin Therapeutics Inc.

Jul-09	Galectin Therapeutics Announces New $10 Million Credit Line from Richard E. Uihlein, Sufficient to Cover Expected Expenditures Through June 2026 GALT GlobeNewswire
Jun-10	Galectin Therapeutics to Host Virtual KOL Event to Discuss Belapectin for Treatment of MASH Cirrhosis and Portal Hypertension GALT GlobeNewswire
May-15	Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2025 and Provides Business Update GALT GlobeNewswire
May-12	Galectin Therapeutics Presented NAVIGATE Trial Results at the European Association for the Study of the Liver (EASL) 2025 Congress GALT GlobeNewswire